Abstract:Cytochrome c-initiated activation of apoptotic protease activating factor-1 (Apaf-1) is a key step in the mitochondrial-signaling pathway for the activation of death-executing caspases in apoptosis. This signaling pathway has been implicated in the pathophysiology of various neurological disorders, including ischemic brain injury. In this study, we have cloned a novel rat gene product, designated as Apaf-1-interacting protein (AIP), which functions as a dominant-negative inhibitor of the Apaf-1-caspase-9 pathway. AIP is constitutively expressed in the brain, but at substantially lower levels than Apaf-1 and caspase-9. AIP can directly bind to Apaf-1 in vitro through its N-terminal caspase-recruiting domain, and this protein interaction was increased in cells undergoing apoptosis. Cytosolic extracts from cells overexpressing AIP were highly resistant to cytochrome c-dATP-induced activation of caspase-9 and caspase-3. Gene transfection of AIP into cell lines, including the neuronal-differentiated PC12 cells, potently suppressed apoptosis induced by various pro-apoptotic stimuli. To further investigate the functional role of AIP in primary neurons and in the brain, an adeno-associated virus (AAV) vector carrying the AIP cDNA was constructed. AAV-mediated overexpression of AIP in primary cortical-hippocampal neurons markedly reduced cell death and caspase-3 activation triggered by protein kinase C inhibition, DNA damage, or oxygen-glucose deprivation. Moreover, intracerebral infusion of the AAV vector resulted in robust AIP expression in the hippocampus and significantly promoted CA1 neuronal survival after transient global cerebral ischemia. These results suggest that molecular targeting of the Apaf-1-caspase-9 signaling pathway may be a feasible neuroprotective strategy to enhance the endogenous threshold for caspase activation and prevent neuronal loss in stroke and related disorders.

Establishment of a CRISPR/Cas9 Lentiviral System for Knockout Gene AIP1 of Human

Generation of a Lamin A/C Knockout Human Induced Pluripotent Stem Cell Line (Zjulli007-A) Via CRISPR/Cas9

Generation of a TRPV1 Knockout Human Pluripotent Stem Cell Line (Wae009-a-u) Using CRISPR/Cas9.

[Construction of All-in-one CRISPR/Cas9 Vector System Targeting Mir-101A Gene in Mouse Hepatic Cell Line AML12].

Construction of Asxl2 gene knock out stable NIH3T3 cell line with CRISPR/Cas9n system

CRISPR/Cas9 Mediated Generation of a Ipsc Line EHTJUi005-A-1 with Homozygous Knockout of the SUV39H1 Gene.

CRISPR/Cas9-Mediated Gene Knockout in Cells and Tissues Using Lentivirus.

Establishing a dual knock-out cell line by lentivirus based combined CRISPR/Cas9 and Loxp/Cre system

Generation of a ISL1 homozygous knockout stem cell line (WAe009-A-1G) by episomal vector-based CRISPR/Cas9 system

Highly efficient neuronal gene knockout in vivo by CRISPR-Cas9 via neonatal intracerebroventricular injection of AAV in mice

Construction of GLRX3-knockout HEK 293 cell line by CRISPR/Cas9 technology

Large genomic fragment deletion and functional gene cassette knock-in via Cas9 protein mediated genome editing in one-cell rodent embryos

A robust method for protein depletion based on gene editing

Generation and validation of versatile inducible CRISPRi embryonic stem cell and mouse model

Cloning of a novel Apaf-1-interacting protein: a potent suppressor of apoptosis and ischemic neuronal cell death.

An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells

Generation of Apoptosis-Resistant HEK293 Cells with CRISPR/Cas Mediated Quadruple Gene Knockout for Improved Protein and Virus Production.

Generation of an ELTD1 knockout human embryonic stem cell line by the iCRISPR/Cas9 system

Efficient Generation of Pleg1a-/- and Pleg1b-/- Double Knockout Minipig Fibroblast Cells Using the CRISPR/Cas9 System

Efficient in vivo deletion of a large imprinted lncRNA by CRISPR/Cas9

Generation of a KCNJ11 Homozygous Knockout Human Embryonic Stem Cell Line WAe001-A-12 Using CRISPR/Cas9.